These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21501004)

  • 1. Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies.
    Veenstra TD
    Expert Rev Proteomics; 2011 Apr; 8(2):139-41. PubMed ID: 21501004
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of breast cancer: the quest for markers and therapeutic targets.
    Hondermarck H; Tastet C; El Yazidi-Belkoura I; Toillon RA; Le Bourhis X
    J Proteome Res; 2008 Apr; 7(4):1403-11. PubMed ID: 18311906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological models of breast cancer: one size does not fit all.
    Choong LY; Lim YP
    Expert Rev Proteomics; 2011 Feb; 8(1):5-7. PubMed ID: 21329423
    [No Abstract]   [Full Text] [Related]  

  • 5. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of serum proteomics in breast cancer research].
    Zhu ZM; Hu XF; Zeng R
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
    van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
    Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics beyond proteomics: toward clinical applications.
    Plymoth A; Hainaut P
    Curr Opin Oncol; 2011 Jan; 23(1):77-82. PubMed ID: 21107258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards discovery-driven translational research in breast cancer.
    Celis JE; Moreira JM; Gromova I; Cabezon T; Ralfkiaer U; Guldberg P; Straten PT; Mouridsen H; Friis E; Holm D; Rank F; Gromov P
    FEBS J; 2005 Jan; 272(1):2-15. PubMed ID: 15634327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A; Ferro M
    Mass Spectrom Rev; 2004; 23(6):393-442. PubMed ID: 15290709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
    Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
    Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive markers in breast cancer--the future.
    Faratian D; Bartlett J
    Histopathology; 2008 Jan; 52(1):91-8. PubMed ID: 18171420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.